Citation Impact
Citing Papers
Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice
2016
The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer
2015
Cytokines in inflammatory bowel disease
2014 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
2012
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
Crohn's disease
2012 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
2013
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
2016
Methodological quality and synthesis of case series and case reports
2018 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Myocarditis
2011 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Ulcerative colitis
2016 Standout
Ulcerative colitis
2020 Standout
Chronic hepatitis C virus infection and lipoprotein metabolism
2015
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Neutrophils in cancer: neutral no more
2016 Standout
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013
Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation?
2017
ROS signalling in the biology of cancer
2017 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
2018
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
NADPH oxidases and cancer
2015
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Competing Risks for Death and Cardiac Transplantation in Children With Dilated Cardiomyopathy
2011
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Differences in the management of pediatric and adult onset ulcerative colitis — lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis
2013
Non‐H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US : A longitudinal analysis of the N ational C ancer D ata B ase from 1998 to 2011
2015
Cancers Complicating Inflammatory Bowel Disease
2015
Works of Ming Lin being referenced
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
2016
Enhancing Our Understanding of Current Therapies for Hepatitis C Virus (HCV)
2015
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
2010
M1227 Which Endoscopic or Clinical Factor is Most Predictive of Future Disease Course in Patients With Ulcerative Colitis?
2010
Recombinant Human Growth Hormone Treatment for Dilated Cardiomyopathy in Children
2004
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
2015
Hepatitis C Virus–Associated Cancer
2014